Skip to main content
Erschienen in: World Journal of Surgery 4/2014

01.04.2014

Lobectomy and Prophylactic Central Neck Dissection for Papillary Thyroid Microcarcinoma: Do Involved Lymph Nodes Mandate Completion Thyroidectomy?

verfasst von: Cho Rok Lee, Haiyoung Son, Sohee Lee, Sang-Wook Kang, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Cheong Soo Park

Erschienen in: World Journal of Surgery | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The present study was designed to investigate the necessity of completion thyroidectomy for patients who underwent thyroid lobectomy for low-risk papillary thyroid microcarcinoma (PTMC) that was later pathologically diagnosed as central lymph node (CLN) metastasis.

Methods

Between 1986 and 2001, we assessed 551 patients who underwent thyroidectomy with prophylactic ipsilateral central compartment neck dissection, and 409 patients were followed-up completely. Thyroid lobectomy were performed in 281 and 128 patients, respectively. The patients were divided into two groups according to CLN metastasis. Clinicopathological profiles and follow-up details were investigated by retrospective chart review.

Results

The CLN-positive and -negative groups were comprised of 43 (15.2 %) and 238 patients (84.8 %), respectively. The mean ages of the two groups were not significantly different (p > 0.05). The mean tumor size of the CLN-positive group (6.8 mm) was significantly larger than that of the CLN-negative group (5.6 mm; p < 0.05). Microscopic capsular invasion was significantly higher in the CLN-positive group (51.2 vs. 23.9 %; p < 0.05). Overall, 21 patients (7.4 %, 21/281) experienced recurrence. Among these, 2 (4.7 %, 2/43) and 19 (8.0 %, 19/238) were in the CLN-positive and -negative groups, respectively. There was no significant correlation between CLN metastasis and tumor recurrence.

Conclusions

Postoperative recurrence was lower in the CLN-positive group, and there was no significant correlation between CLN metastasis and tumor recurrence. Our results suggest that it is not necessary to perform completion thyroidectomy for PTMC patients who have undergone thyroid lobectomy and who have been pathologically diagnosed with CLN metastasis.
Literatur
1.
Zurück zum Zitat Ministry for Health WaFA (2011) The Korea Central Cancer Registry, National Cancer Center. Annual Report of Cancer Statistics in Korea in 2009 Ministry for Health WaFA (2011) The Korea Central Cancer Registry, National Cancer Center. Annual Report of Cancer Statistics in Korea in 2009
2.
Zurück zum Zitat Mazzaferri EL (2000) Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract 6:469–476PubMedCrossRef Mazzaferri EL (2000) Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract 6:469–476PubMedCrossRef
3.
Zurück zum Zitat Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911PubMedCrossRef Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911PubMedCrossRef
4.
Zurück zum Zitat Hay ID, Hutchinson ME, Gonzalez-Losada T et al (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980–987 (discussion 987–988)PubMedCrossRef Hay ID, Hutchinson ME, Gonzalez-Losada T et al (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980–987 (discussion 987–988)PubMedCrossRef
5.
Zurück zum Zitat Qubain SW, Nakano S, Baba M et al (2002) Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131:249–256PubMedCrossRef Qubain SW, Nakano S, Baba M et al (2002) Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131:249–256PubMedCrossRef
6.
Zurück zum Zitat Giordano D, Gradoni P, Oretti G et al (2010) Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin Otolaryngol 35:118–124PubMedCrossRef Giordano D, Gradoni P, Oretti G et al (2010) Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin Otolaryngol 35:118–124PubMedCrossRef
8.
Zurück zum Zitat McHenry CR (2011) Prophylactic central compartment neck dissection for papillary thyroid cancer: the search for justification continues. Surgery 150:1058–1060PubMedCrossRef McHenry CR (2011) Prophylactic central compartment neck dissection for papillary thyroid cancer: the search for justification continues. Surgery 150:1058–1060PubMedCrossRef
9.
Zurück zum Zitat American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid Cancer, Cooper DS et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid Cancer, Cooper DS et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef
10.
Zurück zum Zitat Kucuk NO, Tari P, Tokmak E et al (2007) Treatment for microcarcinoma of the thyroid—clinical experience. Clin Nucl Med 32:279–281PubMedCrossRef Kucuk NO, Tari P, Tokmak E et al (2007) Treatment for microcarcinoma of the thyroid—clinical experience. Clin Nucl Med 32:279–281PubMedCrossRef
11.
Zurück zum Zitat Jacquot-Laperriere S, Timoshenko AP, Dumollard JM et al (2007) Papillary thyroid microcarcinoma: incidence and prognostic factors. Eur Arch Otorhinolaryngol 264:935–939PubMedCrossRef Jacquot-Laperriere S, Timoshenko AP, Dumollard JM et al (2007) Papillary thyroid microcarcinoma: incidence and prognostic factors. Eur Arch Otorhinolaryngol 264:935–939PubMedCrossRef
13.
Zurück zum Zitat Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803PubMedCrossRef Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803PubMedCrossRef
14.
Zurück zum Zitat Pelizzo MR, Boschin IM, Toniato A et al (2006) Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol 32:1144–1148PubMedCrossRef Pelizzo MR, Boschin IM, Toniato A et al (2006) Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol 32:1144–1148PubMedCrossRef
15.
Zurück zum Zitat Chow SM, Law SC, Chan JK et al (2003) Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40PubMedCrossRef Chow SM, Law SC, Chan JK et al (2003) Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40PubMedCrossRef
16.
Zurück zum Zitat Besic N, Pilko G, Petric R et al (2008) Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol 97:221–225PubMedCrossRef Besic N, Pilko G, Petric R et al (2008) Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol 97:221–225PubMedCrossRef
18.
Zurück zum Zitat Tubiana M, Schlumberger M, Rougier P et al (1985) Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794–804PubMedCrossRef Tubiana M, Schlumberger M, Rougier P et al (1985) Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794–804PubMedCrossRef
19.
Zurück zum Zitat Samaan NA, Maheshwari YK, Nader S et al (1983) Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 56:1131–1138PubMedCrossRef Samaan NA, Maheshwari YK, Nader S et al (1983) Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 56:1131–1138PubMedCrossRef
20.
Zurück zum Zitat Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407PubMedCentralPubMed Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407PubMedCentralPubMed
22.
Zurück zum Zitat Ito Y, Kudo T, Kobayashi K et al (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg 36:1274–1278. doi:10.1007/s00268-012-1423-5 PubMedCrossRef Ito Y, Kudo T, Kobayashi K et al (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg 36:1274–1278. doi:10.​1007/​s00268-012-1423-5 PubMedCrossRef
23.
Zurück zum Zitat Cheema Y, Olson S, Elson D et al (2006) What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? J Surg Res 134:160–162PubMedCrossRef Cheema Y, Olson S, Elson D et al (2006) What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? J Surg Res 134:160–162PubMedCrossRef
24.
Zurück zum Zitat Lee J, Park JH, Lee CR et al (2013) Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching. Thyroid 23:1408–1415PubMedCrossRef Lee J, Park JH, Lee CR et al (2013) Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching. Thyroid 23:1408–1415PubMedCrossRef
25.
Zurück zum Zitat Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428PubMedCrossRef Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428PubMedCrossRef
26.
Zurück zum Zitat Hay ID, Grant CS, van Heerden JA et al (1992) Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139–1146 (discussion 1146–1137)PubMed Hay ID, Grant CS, van Heerden JA et al (1992) Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139–1146 (discussion 1146–1137)PubMed
27.
Zurück zum Zitat Botella Bolorinos JA, Sancho Rodriguez-Fornos S, Pallas Regueira JA et al (1988) Occult papillary carcinoma of the thyroid gland. Long-term results. Rev Quir Esp 15:274–276PubMed Botella Bolorinos JA, Sancho Rodriguez-Fornos S, Pallas Regueira JA et al (1988) Occult papillary carcinoma of the thyroid gland. Long-term results. Rev Quir Esp 15:274–276PubMed
28.
Zurück zum Zitat Eroglu A, Unal M, Kocaoglu H (1998) Total thyroidectomy for differentiated thyroid carcinoma: primary and secondary operations. Eur J Surg Oncol 24:283–287PubMedCrossRef Eroglu A, Unal M, Kocaoglu H (1998) Total thyroidectomy for differentiated thyroid carcinoma: primary and secondary operations. Eur J Surg Oncol 24:283–287PubMedCrossRef
29.
Zurück zum Zitat Bilimoria KY, Zanocco K, Sturgeon C (2008) Impact of surgical treatment on outcomes for papillary thyroid cancer. Adv Surg 42:1–12PubMedCrossRef Bilimoria KY, Zanocco K, Sturgeon C (2008) Impact of surgical treatment on outcomes for papillary thyroid cancer. Adv Surg 42:1–12PubMedCrossRef
30.
Zurück zum Zitat Shah JP, Loree TR, Dharker D et al (1993) Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg 166:331–335PubMedCrossRef Shah JP, Loree TR, Dharker D et al (1993) Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg 166:331–335PubMedCrossRef
31.
Zurück zum Zitat Hay ID, Grant CS, Bergstralh EJ et al (1998) Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 124:958–964 (discussion 964–956)PubMedCrossRef Hay ID, Grant CS, Bergstralh EJ et al (1998) Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 124:958–964 (discussion 964–956)PubMedCrossRef
32.
Zurück zum Zitat Mazzaferri EL (1999) An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9:421–427PubMedCrossRef Mazzaferri EL (1999) An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9:421–427PubMedCrossRef
33.
Zurück zum Zitat Mendelsohn AH, Elashoff DA, Abemayor E et al (2010) Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg 136:1055–1061PubMedCrossRef Mendelsohn AH, Elashoff DA, Abemayor E et al (2010) Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg 136:1055–1061PubMedCrossRef
34.
35.
Zurück zum Zitat Turanli S, Aslan S, Cetin A (2011) Clinical significance of residual occult malignancy in thyroid carcinoma. Am J Otolaryngol 32:398–401PubMedCrossRef Turanli S, Aslan S, Cetin A (2011) Clinical significance of residual occult malignancy in thyroid carcinoma. Am J Otolaryngol 32:398–401PubMedCrossRef
36.
Zurück zum Zitat Tollefsen HR, Shah JP, Huvos AG (1972) Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment. Am J Surg 124:468–472PubMedCrossRef Tollefsen HR, Shah JP, Huvos AG (1972) Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment. Am J Surg 124:468–472PubMedCrossRef
38.
Zurück zum Zitat Caliskan M, Park JH, Jeong JS et al (2012) Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma. Endocr J 59:305–311PubMedCrossRef Caliskan M, Park JH, Jeong JS et al (2012) Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma. Endocr J 59:305–311PubMedCrossRef
Metadaten
Titel
Lobectomy and Prophylactic Central Neck Dissection for Papillary Thyroid Microcarcinoma: Do Involved Lymph Nodes Mandate Completion Thyroidectomy?
verfasst von
Cho Rok Lee
Haiyoung Son
Sohee Lee
Sang-Wook Kang
Jong Ju Jeong
Kee-Hyun Nam
Woong Youn Chung
Cheong Soo Park
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 4/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2348-3

Weitere Artikel der Ausgabe 4/2014

World Journal of Surgery 4/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.